Impact of congenital cytomegalovirus infection on vestibular dysfunction and hearing outcomes in a cohort of children
- PMID: 40325024
- PMCID: PMC12053555
- DOI: 10.1038/s41598-025-98150-5
Impact of congenital cytomegalovirus infection on vestibular dysfunction and hearing outcomes in a cohort of children
Abstract
This study aims to evaluate long-term vestibular function and hearing outcomes in a cohort of children with congenital cytomegalovirus infection (cCMV) using a comprehensive battery of vestibular and hearing tests, and possible relationships between vestibular and cochlear damage and relevant clinical presentation variables of cytomegalovirus (CMV) infection. A prospective cohort study was carried out from June 2016 to December 2023 and included 40 children affected by cCMV. Our sample was composed by 35% males and 65% females, with age at first vestibular assessment ranging from 3 to 8 years old, and 30% (12) were symptomatic at birth. All patients received their diagnosis during the neonatal period, with none diagnosed retrospectively through dried blood spots. The median follow-up period was 5.3 years (ranging from 4.6 to 6.0). Comparing children with and without symptoms related to CMV, the presence of hearing loss (50% vs. 0.0%, p = 0.0002), psychomotor delay (25% vs. 0.0%, p = 0.024) and vestibular dysfunction (VD) (66.7% vs. 17.9%, p = 0.0075) were significantly increased in symptomatic patients. The VD was confirmed with a reduced gain of the lateral semicircular canals (LSCC) at the video head impulse test (vHIT) (58.3% vs. 17.9%, p = 0.021), and with the absence of response at cervical vestibular evoked myogenic potentials (cVEMPs) (54.5% vs. 3.7%, p = 0.0009). Comparing children with and without VD, we found a significant presence of reduced LSCC gain during the vHIT (93.3% vs. 0.0%, p < 0.0001), of an exclusive alteration in cVEMPs (61.5% vs. 0.0%, p < 0.0001), of hearing loss (46.2% vs. 0.0%, p = 0.0004), of patients with symptoms related to cCMV at birth (61.5% vs. 14.8%, p = 0.0075), of pathological neuroimaging at onset (61.5% vs. 7.4%, p = 0.0006), presence of antiviral therapy (61.5% vs. 11.1%, p = 0.0017) and positive viremia at onset (100% vs. 63%, p = 0.018). Finally, about time of maternal CMV infection the first trimester was associated to children with VD, while the third trimester to children without VD. cCMV infection can involve the entire inner ear: vestibular function seems to be more affected than cochlear function. Therefore, vestibular evaluation should be included in the audiological work up and follow-up in children with cCMV.
Keywords: Children; Congenital cytomegalovirus; Cytomegalovirus; Vestibular dysfunction.
© 2025. The Author(s).
Conflict of interest statement
Declarations. Competing interests: The authors declare no competing interests.
Figures
Similar articles
-
Long-term outcome of vestibular function and hearing in children with congenital cytomegalovirus infection: a prospective cohort study.Eur Arch Otorhinolaryngol. 2023 Jul;280(7):3141-3147. doi: 10.1007/s00405-022-07816-7. Epub 2023 Jan 16. Eur Arch Otorhinolaryngol. 2023. PMID: 36645498 Free PMC article.
-
Audiovestibular Consequences of Congenital Cytomegalovirus Infection: Greater Vulnerability of the Vestibular Part of the Inner Ear.Ear Hear. 2022 Nov-Dec 01;43(6):1730-1739. doi: 10.1097/AUD.0000000000001240. Epub 2022 Oct 18. Ear Hear. 2022. PMID: 35687026
-
Vestibular Function in Children With a Congenital Cytomegalovirus Infection: 3 Years of Follow-Up.Ear Hear. 2021 Jan/Feb;42(1):76-86. doi: 10.1097/AUD.0000000000000904. Ear Hear. 2021. PMID: 32590628
-
Auditory and Vestibular Involvement in Congenital Cytomegalovirus Infection.Pathogens. 2024 Nov 20;13(11):1019. doi: 10.3390/pathogens13111019. Pathogens. 2024. PMID: 39599572 Free PMC article. Review.
-
Congenital cytomegalovirus infection inducing non-congenital sensorineural hearing loss during childhood; a systematic review.Int J Pediatr Otorhinolaryngol. 2018 Dec;115:156-164. doi: 10.1016/j.ijporl.2018.10.005. Epub 2018 Oct 4. Int J Pediatr Otorhinolaryngol. 2018. PMID: 30368378
Cited by
-
Cochlear Implant in Children with Congenital CMV Infection: Long-Term Results from an Italian Multicentric Study.Children (Basel). 2025 Jul 10;12(7):908. doi: 10.3390/children12070908. Children (Basel). 2025. PMID: 40723101 Free PMC article.
References
-
- Leruez-Ville, M. et al. Corrigendum to ‘Consensus recommendation for prenatal, neonatal and postnatal management of congenital cytomegalovirus infection from the European congenital infection initiative (ECCI)’ [The Lancet Regional Health—Europe 40 (2024) 100892]. Lancet Reg. Health Eur.42, 100974 (2024). - PMC - PubMed
-
- Korndewal, M. J. et al. Long-term impairment attributable to congenital cytomegalovirus infection: A retrospective cohort study. Dev. Med. Child Neurol.59(12), 1261–1268. 10.1111/dmcn.13556 (2017). - PubMed
-
- Dollard, S. C., Grosse, S. D. & Ross, D. S. New estimates of the prevalence of neurological and sensory sequelae and mortality associated with congenital cytomegalovirus infection. Rev. Med. Virol.17(5), 355–363. 10.1002/rmv.544 (2007). - PubMed
MeSH terms
LinkOut - more resources
Full Text Sources
Medical